Tamoxifen
Showing 26 - 50 of 865
Breast Cancer Trial in Toulouse (Treatment requiring adjuvant Hormonal Therapy (HT) with tamoxifen.)
Recruiting
- Breast Cancer
- Treatment requiring adjuvant Hormonal Therapy (HT) with tamoxifen.
-
Toulouse, FranceInstitut Universitaire du Cancer de Toulouse - Oncopole
Mar 28, 2022
Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)
Not yet recruiting
- Breast Cancer, Early Breast Cancer
- Camizestrant
- +5 more
- (no location specified)
Jul 11, 2023
Metastatic Breast Cancer, Hormone Receptor Positive Trial in United States (Palbociclib, Tamoxifen, Fulvestrant)
Completed
- Metastatic Breast Cancer
- Hormone Receptor Positive
- Palbociclib
- +2 more
-
San Francisco, California
- +8 more
Feb 16, 2022
Breast Cancer, Breast Cancer - Female, Breast Cancer - Male Trial in Tampa (Tamoxifen, Ribociclib, Goserelin)
Completed
- Breast Cancer
- +2 more
- Tamoxifen
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 13, 2022
Ovarian Cancer Trial in Sydney (SUBA-itraconazole, Tamoxifen)
Not yet recruiting
- Ovarian Cancer
- SUBA-itraconazole
- Tamoxifen
-
Sydney, New South Wales, AustraliaKinghorn Cancer Centre, St. Vincent's Hospital
Dec 13, 2021
Breast Cancer Trial in Beijing, Guangzhou (TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen, Placebo capsules, Letrozole,
Not yet recruiting
- Breast Cancer
- TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen
- Placebo capsules, Letrozole, Anastrozole, Tamoxifen
-
Beijing, Beijing, China
- +1 more
Mar 10, 2023
Tamoxifen in Breast Cancer and in Women at High-Risk of Breast
Active, not recruiting
- Breast Cancer
- +3 more
- citalopram hydrobromide
- +10 more
-
Indianapolis, Indiana
- +3 more
Feb 18, 2022
Estrogen Receptor Positive Breast Cancer Trial in Houston, Sugar Land (TAK-228, Tamoxifen)
Completed
- Estrogen Receptor Positive Breast Cancer
- TAK-228
- Tamoxifen
-
Houston, Texas
- +2 more
Aug 27, 2021
Neutrophil Extracellular Traps Formation in Breast Cancer
Recruiting
- Breast Carcinoma
- Biospecimen Collection
- Electronic Health Record Review
-
Houston, TexasM D Anderson Cancer Center
Sep 27, 2022
Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Infigratinib, Tamoxifen, Omnipaque 350)
Recruiting
- Breast Cancer
- +3 more
- Infigratinib
- +3 more
-
Stanford, CaliforniaStanford University
Feb 16, 2022
Breast Cancer Trial in Milan (Tamoxifen, Placebo)
Active, not recruiting
- Breast Cancer
- Tamoxifen
- Placebo
-
Milan, ItalyEuropean Institute of Oncology
Aug 12, 2021
COVID-19 Trial (Drug: Isotretinoin plus Tamoxifen, Aerosolized Isotretinoin plus Tamoxifen)
Not yet recruiting
- COVID-19
- Drug: Isotretinoin plus Tamoxifen
- Aerosolized Isotretinoin plus Tamoxifen
- (no location specified)
Jul 10, 2021
Breast Cancer Female Trial (All trans-retinoic acid, 13-Cis Retinoic Acid plus Tocopherol, Mifepristone)
Not yet recruiting
- Breast Cancer Female
- All trans-retinoic acid
- +6 more
- (no location specified)
Aug 17, 2021
Ductal Carcinoma in Situ Trial (Tamoxifen, Exemestane, Letrozole)
Not yet recruiting
- Ductal Carcinoma in Situ
- Tamoxifen
- +5 more
- (no location specified)
Oct 13, 2023
Breast Cancer Trial in Singapore (Tamoxifen)
Recruiting
- Breast Cancer
- Tamoxifen
-
Singapore, SingaporeNational Cancer Centre
Jul 5, 2021
Breast Cancer. Real Clinical Practice in Russia
Recruiting
- Breast Cancer
- Neoadjuvant Endocrine Therapy
- Tamoxifen 20mg
- +4 more
-
Moscow, Russian FederationBlokhin's Russian Cancer Research Center
Apr 5, 2023
ER+ Breast Cancer Trial in Jakarta (Tamoxifen dose adjustment)
Completed
- ER+ Breast Cancer
- Tamoxifen dose adjustment
-
Jakarta, DKI Jakarta, IndonesiaMRCCC Siloam Hospital Semanggi
Aug 4, 2021
Metastatic Breast Cancer Trial in Pittsburgh (Fulvestrant, Tamoxifen, Palbociclib)
Active, not recruiting
- Metastatic Breast Cancer
- Fulvestrant
- +2 more
-
Pittsburgh, PennsylvaniaMagee-Womens Hospital UPMC
Jul 22, 2021
HR Positive HER2 Negative Advanced Breast Cancer Trial in Tianjin (Chidamide)
Recruiting
- HR Positive HER2 Negative Advanced Breast Cancer
-
Tianjin, China天津市肿瘤医院
May 26, 2023
Breast Cancer Trial in Jakarta (Tamoxifen)
Active, not recruiting
- Breast Cancer
- Tamoxifen
-
Jakarta, DKI Jakarta, IndonesiaMRCCC Siloam Hospitals Semanggi
Aug 12, 2022
Male Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma Trial in Boston
Not yet recruiting
- Male Breast Cancer
- +2 more
- Tamoxifen
- +3 more
-
Boston, Massachusetts
- +1 more
Aug 12, 2022
Breast Tumors Trial in Worldwide (Palbociclib, Placebo, Tamoxifen)
Active, not recruiting
- Breast Neoplasms
- Palbociclib
- +3 more
-
Nagoya, Aichi, Japan
- +22 more
Apr 4, 2022
Breast Cancer Invasive Trial in Seoul (Leuplin or zoladex)
Recruiting
- Breast Cancer Invasive
- Leuplin or zoladex
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 16, 2022